Madrigal Pharmaceuticals Aktie
438,80
EUR
-37,90
EUR
-7,95
%
516,79
USD
+2,06
USD
+0,40
%
Werbung
Madrigal Pharmaceuticals Aktie Analyse
| 10.06.19 | Madrigal Pharmaceuticals Buy | B. Riley FBR | |
| 28.02.19 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. | |
| 14.12.18 | Madrigal Pharmaceuticals Outperform | Wolfe Research | |
| 01.06.18 | Madrigal Pharmaceuticals Outperform | Oppenheimer & Co. Inc. | |
| 01.06.18 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. | |
| 30.01.18 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. | |
| 06.12.17 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. | |
| 29.11.17 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. | |
|
Werbung
|
|||
Werbung
Werbung